AU2003270099A1 - Generation of recombinant influenza virus using baculovirus delivery vector - Google Patents
Generation of recombinant influenza virus using baculovirus delivery vectorInfo
- Publication number
- AU2003270099A1 AU2003270099A1 AU2003270099A AU2003270099A AU2003270099A1 AU 2003270099 A1 AU2003270099 A1 AU 2003270099A1 AU 2003270099 A AU2003270099 A AU 2003270099A AU 2003270099 A AU2003270099 A AU 2003270099A AU 2003270099 A1 AU2003270099 A1 AU 2003270099A1
- Authority
- AU
- Australia
- Prior art keywords
- generation
- influenza virus
- delivery vector
- recombinant influenza
- baculovirus delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000701447 unidentified baculovirus Species 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40769502P | 2002-09-04 | 2002-09-04 | |
US60/407,695 | 2002-09-04 | ||
PCT/EP2003/009375 WO2004022760A1 (en) | 2002-09-04 | 2003-08-23 | Generation of recombinant influenza virus using baculovirus delivery vector |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003270099A1 true AU2003270099A1 (en) | 2004-03-29 |
Family
ID=31978508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003270099A Abandoned AU2003270099A1 (en) | 2002-09-04 | 2003-08-23 | Generation of recombinant influenza virus using baculovirus delivery vector |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1534845A1 (en) |
AU (1) | AU2003270099A1 (en) |
WO (1) | WO2004022760A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010277310B2 (en) | 2009-07-31 | 2015-01-15 | Seqirus UK Limited | Reverse genetics systems |
US8513006B2 (en) | 2010-09-14 | 2013-08-20 | University of Pittsburgh—of the Commonwealth System of Higher Education | Tetravalent influenza vaccine and use thereof |
FR2978456B1 (en) | 2011-07-27 | 2015-02-20 | Genethon | BACULOVIRAL SYSTEM FOR THE EXPRESSION OF A GENE THERAPEUTIC VECTOR |
-
2003
- 2003-08-23 AU AU2003270099A patent/AU2003270099A1/en not_active Abandoned
- 2003-08-23 EP EP03750434A patent/EP1534845A1/en not_active Withdrawn
- 2003-08-23 WO PCT/EP2003/009375 patent/WO2004022760A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004022760A1 (en) | 2004-03-18 |
EP1534845A1 (en) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL163546A0 (en) | An influenza viral vector containing incorporationsequences | |
ZA200107284B (en) | Stable recombinant influenza viruses free of helper viruses. | |
AU2003238456A1 (en) | Viral vector | |
AU3328900A (en) | Influenza virus hemagglutinin-binding peptides | |
HK1067891A1 (en) | Influenza vaccine composition | |
AU2003274397A1 (en) | Production of pseudotyped recombinant aav virions | |
AU2002322719A1 (en) | Delivery of therapeutic capable agents | |
AU2003295502A1 (en) | Adenoviral vector vaccine | |
AU2002364893A1 (en) | Delivery of medicaments to the nail | |
AU2003277021A1 (en) | Glycosylceramide analogues | |
AU2003217227A1 (en) | Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach | |
AU2002325683A1 (en) | Recombinant vector derived from adeno-associated virus for gene therapy | |
AU2003219057A1 (en) | Recombinant drug-sensitive vaccinia virus as smallpox vaccine | |
AU2003278776A1 (en) | Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection | |
AU2003300831A1 (en) | Recombinant vaccine against flavivirus infection | |
AU2003294757A1 (en) | Formulations useful against hepatitis c virus infections | |
AU2003279551A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
EP1549346A4 (en) | Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants | |
AU2003270099A1 (en) | Generation of recombinant influenza virus using baculovirus delivery vector | |
AU2003238039A1 (en) | Nasal peptide pharmaceutical formulation | |
AU2002339370A1 (en) | Nasal Spray | |
AU2003249059A1 (en) | Use of vaccinia virus deleted for the e3l gene as a vaccine vector | |
AU2002240942A1 (en) | Improved delivery of benefit agents | |
AU2003242222A1 (en) | A recombinant anti-enveloped virus peptide and its preparation | |
AU2003228863A1 (en) | Immunogenic peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |